We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
-3.33%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$9.4B
AUM Growth
-$1.47B
(-14%)
Cap. Flow
-$936M
Cap. Flow
% of AUM
-9.97%
Top 10 Holdings %
Top 10 Hldgs %
27.51%
Holding
1,295
New
171
Increased
621
Reduced
344
Closed
156
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$109M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$60M |
| 3 |
Qualcomm
QCOM
|
+$51.7M |
| 4 |
Texas Instruments
TXN
|
+$40M |
| 5 |
Microsoft
MSFT
|
+$37.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.72B |
| 2 |
Intel
INTC
|
+$70.3M |
| 3 |
KraneShares CSI China Internet ETF
KWEB
|
+$60.1M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$43.5M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.79% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 10.38% |
| 4 | Energy | 7.34% |
| 5 | Consumer Discretionary | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Elevance Health
ELV
$81.5B
| $5.84M | 0.06% |
12,848
+6,999
| +120% | +$3.35M |
|
302
Ultragenyx Pharmaceutical
RARE
$2.45B
| $5.83M | 0.06% |
140,690
+64,107
| +84% | +$3.29M |
|
303
General Dynamics
GD
$104B
| $5.83M | 0.06% |
27,456
+3,953
| +17% | +$893K |
|
304
Arista Networks
ANET
$227B
| $5.76M | 0.06% |
204,232
+30,264
| +17% | +$873K |
|
305
Principal Financial Group
PFG
$24.3B
| $5.74M | 0.06% |
79,611
+185
| +0.2% | +$13.3K |
|
306
Medtronic
MDT
$109B
| $5.74M | 0.06% |
71,086
+38,537
| +118% | +$3.46M |
|
307
Natera
NTRA
$38.3B
| $5.74M | 0.06% |
130,938
+19,363
| +17% | +$922K |
|
308
Veracyte
VCYT
$3.7B
| $5.74M | 0.06% |
345,617
+146,636
| +74% | +$3.3M |
|
309
NextEra Energy
NEE
$181B
| $5.73M | 0.06% |
73,036
+52,744
| +260% | +$4.47M |
|
|
MRTX
310
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.71M | 0.06% |
81,712
+17,048
| +26% | +$1.26M |
|
311
lululemon athletica
LULU
$13.5B
| $5.65M | 0.06% |
20,197
-3,012
| -13% | -$934K |
|
312
Magnolia Oil & Gas
MGY
$6.09B
| $5.64M | 0.06% |
284,922
-146,319
| -34% | -$3.24M |
|
313
Walt Disney
DIS
$167B
| $5.61M | 0.06% |
59,515
+47,616
| +400% | +$5.1M |
|
|
RXDX
314
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $5.61M | 0.06% |
+95,032
| New | +$4.35M |
|
315
Walmart Inc
WMT
$885B
| $5.6M | 0.06% |
129,621
+122,646
| +1,758% | +$5.37M |
|
316
McDonald's
MCD
$192B
| $5.59M | 0.06% |
24,246
+21,585
| +811% | +$5.52M |
|
|
SPLK
317
DELISTED
Splunk Inc
SPLK
| $5.59M | 0.06% |
74,328
-242
| -0.3% | -$23.7K |
|
|
CMA
318
DELISTED
Comerica
CMA
| $5.58M | 0.06% |
78,526
+12,863
| +20% | +$1.01M |
|
319
Twist Bioscience
TWST
$5.7B
| $5.54M | 0.06% |
157,248
+14,618
| +10% | +$621K |
|
|
EXAS
320
DELISTED
Exact Sciences
EXAS
| $5.54M | 0.06% |
170,484
+77,903
| +84% | +$3.21M |
|
321
Fate Therapeutics
FATE
$286M
| $5.52M | 0.06% |
246,475
+53,651
| +28% | +$1.55M |
|
322
Linde
LIN
$221B
| $5.43M | 0.06% |
20,162
+13,521
| +204% | +$3.88M |
|
323
L3Harris
LHX
$51.6B
| $5.39M | 0.06% |
25,923
+3,806
| +17% | +$878K |
|
324
Editas Medicine
EDIT
$396M
| $5.36M | 0.06% |
437,761
+94,662
| +28% | +$1.47M |
|
325
Amphenol
APH
$198B
| $5.32M | 0.06% |
158,882
+21,506
| +16% | +$781K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Rafferty Asset Management held 1,295 positions worth $9.4B, down 14% from $10.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Rafferty Asset Management withdrew a net $936M in Q3 2022, closing 156 positions and reducing 344 holdings. Its most notable exit was iShares Russell 1000 Value ETF, an estimated $21.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Rafferty Asset Management opened a new position in American Express worth $28M.
- Rafferty Asset Management's largest Q3 2022 buy was American Express: 207,400 shares worth $28M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q3 2022, an estimated $109M increase.
- Rafferty Asset Management's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.72B.
- Rafferty Asset Management fully exited iShares Russell 1000 Value ETF in Q3 2022, selling an estimated $21.8M.
- Rafferty Asset Management's ten largest holdings make up 28% of its $9.4B portfolio in Q3 2022.
- Rafferty Asset Management opened 171 new positions and closed 156 in Q3 2022.
- Rafferty Asset Management's portfolio value fell 14% quarter-over-quarter to $9.4B.
Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.